Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

Renal resistive index for renovascular hypertension: In the quest of the Holy Grail Arterial hypertension represents a major public health problem that affects more than 1 billion individuals worldwide, and the number significantly increased with the new more aggressive definition (systolic blood pressure [BP] >130 mm Hg) by the American Heart Association. A specific cause of BP elevation cannot be identified in the majority of patients (essential hypertension), while secondary causes can be identified in 5% to 15%, forming the group of secondary hypertension. Until now, more than 50 causes of secondary hypertension have been reported with various incidence. The combination of the increased prevalence of arterial hypertension in the general population and the subsequent huge absolute number of patients along with the large number of secondary causes from a variety of systems and organs renders ideal screening tests as the “Holy Grail” of appropriate management of patients with arterial hypertension.Renovascular hypertension has been traditionally considered the most common cause of secondary hypertension. The advent of renal artery angioplasty for the successful opening of the occluded renal artery made renovascular hypertension a popular research topic during the last 2 to 3 decades of the 20th century. However, two factors have dampened scientific enthusiasm: (1) the failure of renal artery angioplasty to prove its superiority over http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Clinical Hypertension Wiley

Renal resistive index for renovascular hypertension: In the quest of the Holy Grail

Loading next page...
 
/lp/wiley/renal-resistive-index-for-renovascular-hypertension-in-the-quest-of-ouPxr1H4vM
Publisher
Wiley Subscription Services, Inc., A Wiley Company
Copyright
Copyright © 2018 Wiley Periodicals, Inc.
ISSN
1524-6175
eISSN
1751-7176
D.O.I.
10.1111/jch.13221
Publisher site
See Article on Publisher Site

Abstract

Arterial hypertension represents a major public health problem that affects more than 1 billion individuals worldwide, and the number significantly increased with the new more aggressive definition (systolic blood pressure [BP] >130 mm Hg) by the American Heart Association. A specific cause of BP elevation cannot be identified in the majority of patients (essential hypertension), while secondary causes can be identified in 5% to 15%, forming the group of secondary hypertension. Until now, more than 50 causes of secondary hypertension have been reported with various incidence. The combination of the increased prevalence of arterial hypertension in the general population and the subsequent huge absolute number of patients along with the large number of secondary causes from a variety of systems and organs renders ideal screening tests as the “Holy Grail” of appropriate management of patients with arterial hypertension.Renovascular hypertension has been traditionally considered the most common cause of secondary hypertension. The advent of renal artery angioplasty for the successful opening of the occluded renal artery made renovascular hypertension a popular research topic during the last 2 to 3 decades of the 20th century. However, two factors have dampened scientific enthusiasm: (1) the failure of renal artery angioplasty to prove its superiority over

Journal

Journal of Clinical HypertensionWiley

Published: Jan 1, 2018

Keywords: ; ; ; ; ;

References

You’re reading a free preview. Subscribe to read the entire article.


DeepDyve is your
personal research library

It’s your single place to instantly
discover and read the research
that matters to you.

Enjoy affordable access to
over 12 million articles from more than
10,000 peer-reviewed journals.

All for just $49/month

Explore the DeepDyve Library

Unlimited reading

Read as many articles as you need. Full articles with original layout, charts and figures. Read online, from anywhere.

Stay up to date

Keep up with your field with Personalized Recommendations and Follow Journals to get automatic updates.

Organize your research

It’s easy to organize your research with our built-in tools.

Your journals are on DeepDyve

Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.

All the latest content is available, no embargo periods.

See the journals in your area

Monthly Plan

  • Read unlimited articles
  • Personalized recommendations
  • No expiration
  • Print 20 pages per month
  • 20% off on PDF purchases
  • Organize your research
  • Get updates on your journals and topic searches

$49/month

Start Free Trial

14-day Free Trial

Best Deal — 39% off

Annual Plan

  • All the features of the Professional Plan, but for 39% off!
  • Billed annually
  • No expiration
  • For the normal price of 10 articles elsewhere, you get one full year of unlimited access to articles.

$588

$360/year

billed annually
Start Free Trial

14-day Free Trial